Target intelligence / Profile preview

S-phase kinase-associated protein 1 (SKP1)

Target
SKP1
Molecular classification
Enzyme, SCF ubiquitin ligase complex component
01

Overview

S-phase kinase-associated protein 1 (SKP1) is a core adaptor protein and a key component of the SCF (SKP1-CUL1-F-box) E3 ubiquitin ligase complex. This enzyme binds F-box proteins and facilitates ubiquitin-dependent proteolysis of various regulatory proteins, particularly those involved in cell cycle progression and signal transduction. SKP1 modulates levels of proteins such as cyclins and beta-catenin, and thereby influences cell cycle transitions, proliferation, and transcription. Due to its essential roles, SKP1 and the SCF complex are considered important targets in oncology and have been implicated in disease processes where proteostasis and cell cycle regulation are dysregulated[2][3][8][9].

Other names
Cyclin-A/CDK2-associated protein p19EMC19OCP-2OCP-IIOCP2
02

Mechanism of action

Inhibition of SCF (SKP1-CUL1-F-box protein) complex activity (for molecules targeting this pathway) Inhibition of ubiquitin-mediated protein degradation (for proteasome inhibitors and related agents) (*inferred*)

03

Biological functions

Ubiquitin-dependent proteolysisCell cycle regulationBeta-catenin signaling regulationTranscription regulation
04

Disease associations

Cancer (*inferred based on the role of SCF complex and protein degradation in oncogenesis*)Other (due to involvement in fundamental cell cycle and proteostasis pathways)
05

Safety considerations

Cell cycle arrest and toxicity in non-tumor cells (since SKP1 functions in fundamental cellular processes)Potential for immune or hematopoietic suppression

Beyond the preview

Go deeper on S-phase kinase-associated protein 1 (SKP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on S-phase kinase-associated protein 1 (SKP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call